Parkinsons 2025 | Parkinsons Conferences 2025

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Advancing Science: Psychiatric & Cognitive Impacts

- Parkinsons 2025

Welcome Message

Welcome to the 4th International Conference on Parkinson’s, Huntington's & Movement Disorders

Vienna, Austria | June 16-17, 2025

We are not here to talk about the problem. We’re here to solve it.

Welcome to Vienna, where the brightest minds are coming together to transform the future of Parkinson’s, Huntington’s, and movement disorders. This isn’t just another conference. This is a catalyst for change, where science, compassion, and innovation converge to break new ground.

The next few days are about bold thinking, disruptive innovations, and cutting-edge solutions that will pave the way for a future where movement disorders are no longer a limiting factor in people’s lives. Together, we will chart a path forward and build the future of movement disorder care.

What’s waiting for you?

Be Part of History:

In a world where possibilities are expanding every day, you are at the forefront of the movement. Expect to witness new insights and advancements that challenge the boundaries of what’s possible for movement disorders.

Unlock Bold Conversations:

This is where ideas collide. With leading innovators, visionaries, and research pioneers, get ready to explore uncharted territories and engage in dialogues that promise to reshape the future of care.

Leave with Purpose:

This isn’t just about learning—it’s about transforming action into results. Gain insightful strategies and practical solutions to empower patients and take the next big leap in treating movement disorders

We’re here to make history. Join us as we challenge the status quo, explore untapped possibilities, and take bold steps toward transforming the lives of those affected by movement disorders.

Welcome to the future. Welcome to Parkinson's 2025.

Market Analysis

Market Analysis: Parkinson’s, Huntington’s, and Movement Disorders (2013–2033)

Past Decade: Expanding Frontiers (2013–2023)

Parkinson’s Disease: Introduction of advanced therapies like deep brain stimulation (DBS) and dopamine agonists improved patient outcomes.

Huntington's Disease: Genetic research and the development of antisense oligonucleotides marked significant breakthroughs.

Movement Disorders: Increased awareness and diagnosis fueled demand for targeted therapies and assistive devices.

Current Landscape (2024)

Innovation-Driven Growth:

Advances in gene therapies and CRISPR-based research are reshaping treatment possibilities.

Wearable technology and AI-powered tools enhance early detection and patient management.

Regional Highlights:

North America dominates with high healthcare spending and research initiatives.

Europe and Asia-Pacific show strong growth due to increased prevalence and investments in healthcare infrastructure.

Future Trends and Projections (2024–2033)

Parkinson’s Market: Projected to grow at a CAGR of 7%, reaching $8 billion by 2030.

Huntington's Market: Expected to expand rapidly, driven by ongoing clinical trials for disease-modifying therapies.

Movement Disorders: Innovations in brain-computer interfaces and non-invasive neuromodulation will fuel market growth.

Digital Health Integration: Telemedicine and digital platforms will become integral for patient monitoring and therapy adjustments.

About

The 4th International Conference on Parkinson’s, Huntington’s & Movement Disorders (Parkinsons 2025) will take place on June 16-17, 2025, in Vienna, Austria. This conference provides a multidisciplinary platform for the global scientific community to explore advancements in the understanding, diagnosis, and management of movement disorders, including Parkinson’s and Huntington’s diseases.

With a focus on cutting-edge research and clinical innovations, the conference will feature a robust scientific program encompassing keynote presentations, technical workshops, and discussions on novel therapeutic approaches.

Key Topics

Parkinsons Disease: Advances in Research and Treatment
Huntington’s Disease: Genetic Insights and Interventions
Movement Disorders: Neurodegenerative Mechanisms and Therapies
Multidisciplinary Approaches in Patient-Centered Care
Emerging Trends: Drug Development, Rehabilitation, and Technology

Event Features

Peer-reviewed scientific sessions and presentations
Opportunities to present research in poster and oral formats
Networking opportunities with industry leaders and researchers
In-depth discussions on future directions and clinical strategies

Parkinsons 2025 aims to bridge gaps in understanding movement disorders and improve clinical outcomes through collaborative efforts and shared knowledge.

For additional details, including registration and abstract submission, please visit the relevant sections of the website.

List of Sessions

Track 1: Neurogenetics Advances

Neurogenetics advances focuses on understanding the genetic factors contributing to movement disorders. This track explores the latest discoveries in genetic mutations and their role in conditions like Parkinson’s and Huntington’s diseases. Researchers will discuss how gene therapy, genetic screening, and personalized medicine could transform the way we diagnose, treat, and even prevent these neurodegenerative diseases in the future.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 2: Cognitive and Behavioural Dysfunctions

Cognitive and behavioural dysfunctions examines the mental and emotional challenges faced by patients with movement disorders. This track looks at how conditions like Parkinson’s and Huntington’s impact memory, mood, and behaviour. It also highlights the latest research on diagnosing and managing these cognitive and psychiatric symptoms, offering new approaches to improving the mental well-being of patients.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 3: Motor Symptoms in Neurodegenerative Diseases

Motor symptoms in neurodegenerative diseases explores the common and debilitating symptoms of movement disorders, such as tremors, rigidity, and bradykinesia. Experts will discuss the latest insights into the underlying mechanisms of these symptoms and how current and emerging treatments are helping patients manage their motor challenges more effectively.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 4: Neuroimaging Insights

Neuroimaging Insights dives into the role of advanced imaging technologies, such as MRI and PET scans, in understanding movement disorders. This track will explore how these tools help us visualize brain changes in diseases like Parkinson’s and Huntington’s, aiding in diagnosis, tracking disease progression, and evaluating the effectiveness of treatments.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 5: Clinical Neurophysiology

Clinical neurophysiology focuses on using electrical recordings to understand the brain's function in movement disorders. This track covers diagnostic techniques like eeg and emg, as well as their role in monitoring disease progression and assessing treatment outcomes. These methods are crucial for pinpointing abnormalities in brain activity and muscle control in patients.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 6: Neuromodulation Therapies

Neuromodulation therapies examines non-invasive treatments that aim to adjust brain activity in patients with movement disorders. Technologies like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are at the forefront of this field, and this track will discuss their potential to improve motor and cognitive functions in conditions like Parkinson’s and Huntington’s.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 7: Movement Disorder Syndromes

Movement disorder syndromes explores the wide range of disorders that cause abnormal movements, including Parkinson’s disease, Huntington’s disease, and rare syndromes. This track will focus on the diagnostic challenges, clinical features, and evolving treatment options, offering practical solutions for managing these complex conditions.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 8: Neuroprotective Agents

Neuroprotective agents explores drugs and treatments designed to protect the brain from damage in neurodegenerative diseases. This track covers the latest research on medications and therapies aimed at slowing the progression of conditions like Parkinson’s and Huntington’s, helping preserve cognitive and motor function for as long as possible.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 9: Parkinsonism Subtypes and Variants

Parkinsonism subtypes and variants delve into the different forms of Parkinsonism beyond the classic Parkinson’s disease. It focuses on the diagnostic criteria and treatment approaches for atypical Parkinsonism and secondary Parkinsonism, helping researchers better understand these conditions and improve patient care.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 10: Dyskinesia Management

Dyskinesia Management focuses on controlling the involuntary movements that are often a side effect of Parkinson’s treatment. This track covers the latest methods for managing dyskinesia’s, including adjustments to medication regimens, the use of deep brain stimulation, and other therapeutic interventions to improve patients' quality of life.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 11: Huntington’s disease Mechanisms

Huntington’s disease mechanisms provides an in-depth look at the genetic and molecular causes of Huntington’s disease. Researchers will discuss how the disease progresses at the cellular level, the role of protein aggregation, and the latest treatments aiming to slow or stop these processes.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 12: Ataxia and Gait Abnormalities

Ataxia and gait abnormalities addresses coordination and walking difficulties that often accompany neurodegenerative diseases. This track explores the causes of gait disturbances, the role of the cerebellum, and the latest strategies for improving mobility through rehabilitation, assistive devices, and medical treatments.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 13: Dystonia Mechanisms and Therapies

Dystonia mechanisms and therapies delves into the causes and treatments for dystonia, a condition marked by involuntary muscle contractions that result in abnormal postures. This track will explore the neurophysiological mechanisms behind dystonia and review treatments like botulinum toxin injections, deep brain stimulation, and medications that help manage symptoms.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 14: Spasticity Management Approaches

Spasticity management approaches looks at how to treat the muscle stiffness and spasms that often occur in neurodegenerative diseases. This track will cover various therapeutic options, including physical therapy, medications, and surgical interventions like intrathecal baclofen therapy, to help patients regain mobility and independence.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 15: Deep Brain Stimulation Advances

Deep brain stimulation advances focuses on the use of deep brain stimulation (DBS) to treat movement disorders like Parkinson’s and dystonia. This track will discuss the latest technological advancements in DBS, how it works to improve motor function, and the on-going improvements in patient selection, surgical techniques, and post-operative care.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 16: Cerebellar Disorders and Their Impact

Cerebellar disorders and their impact addresses conditions that affect the cerebellum, a part of the brain responsible for coordinating movement. This track will cover the pathophysiology of cerebellar disorders, the impact they have on motor control, and the current treatments that can help manage symptoms and improve patient quality of life.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 17: Neurorehabilitation Strategies

Neurorehabilitation Strategies focuses on helping patients with movement disorders regain lost function and improve their quality of life. This track explores the latest rehabilitation techniques, including physical, occupational, and speech therapy, and emphasizes the importance of a comprehensive, multidisciplinary approach to treatment.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 18: Behavioural Neurology in movement disorders

Behavioural neurology in movement disorders looks at the intersection of movement and behaviour, examining how neurodegenerative diseases affect mental processes, mood, and cognition. This track explores the latest research on the behavioural aspects of Parkinson’s, Huntington’s, and other movement disorders, as well as strategies for managing these challenges.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 19: Biomarker Discovery and Validation

Biomarker Discovery and Validation focuses on identifying biological markers that can help diagnose and monitor movement disorders. This track will cover the latest research into genetic, protein, and imaging Biomarkers, discussing how these tools can help doctors better understand the progression of diseases and tailor treatments to individual patients.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 20: Neuroepidemiology Trends

Neuroepidemiology Trends examines the patterns, causes, and effects of movement disorders in different populations. This track will highlight the latest findings in epidemiological studies, exploring risk factors, demographic trends, and environmental influences that contribute to the development of Parkinson’s, Huntington’s, and other neurodegenerative diseases.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 21: Pharmacological Innovations

Pharmacological Innovations explores the development of new drugs and treatments for movement disorders. This track will focus on the latest advancements in neuropharmacology, including new classes of drugs and therapies that aim to improve motor and cognitive symptoms, slow disease progression, and enhance the overall quality of life for patients.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 22: Gene-based and Molecular Therapies

Gene-based and Molecular Therapies looks at how gene therapy and molecular approaches can be used to treat movement disorders. This track will explore the cutting-edge research into gene editing, RNA-based therapies, and viral vector techniques that aim to modify the genetic causes of diseases like Huntington’s and Parkinson’s.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 23: Autonomic Dysfunctions in Neurodegenerative Diseases

Autonomic Dysfunctions in Neurodegenerative Diseases addresses the dysfunctions of the autonomic nervous system, such as problems with blood pressure, heart rate, and digestion, that are common in movement disorders. This track will explore how these symptoms arise, the diagnostic tools available, and the treatments that can help manage autonomic dysfunctions in diseases like Parkinson’s and Huntington’s.

Related Conferences:

Related Associations and Societies:

Related Journals:

Track 24: Emerging Clinical Trials and Studies

Emerging Clinical Trials and Studies highlight the latest clinical research on treatments for movement disorders. This track will cover on-going trials, innovative methodologies, and emerging therapies that hold the potential to change the way we treat diseases like Parkinson’s and Huntington’s, providing attendees with a glimpse into the future of movement disorder treatment.

Track 25: Case Reports and Case Series

Case Reports and Case Series offers a closer look at individual patient experiences with movement disorders, providing insights into rare or complex cases. This track will feature reports that highlight unusual diagnoses, treatment approaches, and outcomes, offering valuable lessons for clinicians and researchers working with patients with movement disorders.

Related Conferences:

Related Associations and Societies: